Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Journal of Cancer Metastasis and Treatment|November 15, 2021
The multifunctional role of Notch signaling in multiple myelomaHayley M Sabol, Jesus Delgado-CalleCancer Research|February 24, 2026
Acting on dormancy: the interplay between the actin cytoskeleton and tumor cell dormancyHayley M Sabol, Jose Javier Bravo-Cordero, Lucia BorrielloNeoplasia (New York, N.Y.)|April 7, 2022
Notch3 signaling between myeloma cells and osteocytes in the tumor niche promotes tumor growth and bone destructionHayley M Sabol, Tânia Amorim, Cody Ashby, et al.Haematologica|February 22, 2024
A NOTCH3-CXCL12-driven myeloma-tumor niche signaling axis promotes chemoresistance in multiple myelomaHayley M Sabol, Cody Ashby, Manish Adhikari, et al.Haematologica|November 20, 2023
Pharmacologic targeting of the p62 ZZ domain enhances both anti-tumor and bone-anabolic effects of bortezomib in multiple myelomaSilvia Marino, Daniela N Petrusca, Ryan T Bishop, et al.Haematologica|November 28, 2024
A novel CCL3-HMGB1 signaling axis regulating osteocyte RANKL expression in multiple myelomaAric Anloague, Hayley M Sabol, Japneet Kaur, et al.Research Square|April 1, 2024
Single-cell Transcriptome Analysis Identifies Senescent Osteocytes as Contributors to Bone Destruction in Breast Cancer MetastasisManish Adhikari, Japneet Kaur, Hayley M Sabol, et al.Journal of Experimental & Clinical Cancer Research : CR|January 4, 2026
Targeting NOTCH3 to eradicate dormant and therapy-resistant multiple myeloma cellsHayley M Sabol, Bethany C Paxton, Aric Anloague, et al.Cancer Research|September 23, 2024
Single-Cell Transcriptomic Analysis Identifies Senescent Osteocytes That Trigger Bone Destruction in Breast Cancer MetastasisJapneet Kaur, Manish Adhikari, Hayley M Sabol, et al.Cancer Research|August 5, 2021
Targeting Notch Inhibitors to the Myeloma Bone Marrow Niche Decreases Tumor Growth and Bone Destruction without Gut ToxicityHayley M Sabol, Adam J Ferrari, Manish Adhikari, et al.Pageof 2